Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Biomira's CA test co-promoted by Immunex

Executive Summary

Immunex has entered a co-promotion agreement with Biomira to market its Truquant BR blood test for the detection of recurrent breast cancer. The test will continue to be exclusively distributed in the US by Polymedco.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Co-Promotion
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register